Free Trial
OTCMKTS:PMCBD

PharmaCyte Biotech (PMCBD) Stock Price, News & Analysis

PharmaCyte Biotech logo
$1.61 +0.00 (+0.12%)
As of 01/29/2025

About PharmaCyte Biotech Stock (OTCMKTS:PMCBD)

Key Stats

Today's Range
$1.61
$1.63
50-Day Range
$1.50
$1.75
52-Week Range
$5.56
$55.50
Volume
2,032 shs
Average Volume
8,831 shs
Market Capitalization
$2.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Laguna Hills, CA.

Receive PMCBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter.

PMCBD Stock News Headlines

PharmaCyte Biotech (PMCB) Earnings Dates & Reports
22x better than Bitcoin… WITHOUT crypto
We’re on the verge of a massive paradigm shift. And it will leave millions of people behind… including you, perhaps. The legendary former hedge fund manager Larry Benedict has discovered a different way to make money from Bitcoin.
PharmaCyte Biotech Inc (PMCB)
Exploring beauty’s biotech frontier
PMCB PharmaCyte Biotech, Inc.
Baltimore Biotech News
See More Headlines

PMCBD Stock Analysis - Frequently Asked Questions

PharmaCyte Biotech's stock was trading at $1.55 at the start of the year. Since then, PMCBD shares have increased by 4.0% and is now trading at $1.6125.
View the best growth stocks for 2025 here
.

Shares of PMCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:PMCBD
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-3,830,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.69 million
Optionable
Not Optionable
Beta
0.27
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:PMCBD) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners